{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:36:48Z","timestamp":1725583008225},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,5]]},"DOI":"10.7759\/cureus.68690","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:30:41Z","timestamp":1725528641000},"source":"Crossref","is-referenced-by-count":0,"title":["Deciphering Complexity: Atypical Hemolytic Uremic Syndrome Unraveled in the Wake of Elective Hip Arthroplasty"],"prefix":"10.7759","author":[{"given":"Gautam N","family":"Bedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Sontakke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smruti A","family":"Mapari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rucha","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris M","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 361:1676-87. 10.1056\/NEJMra0902814","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey MA","year":"2010","unstructured":"Dragon-Durey MA, Sethi SK, Bagga A, et al.. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010, 21:2180-7. 10.1681\/ASN.2010030315","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat C","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, et al.. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016, 31:15-39. 10.1007\/s00467-015-3076-8","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-106153","article-title":"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation","volume":"111","author":"St\u00e5hl AL","year":"2008","unstructured":"St\u00e5hl AL, Vaziri-Sani F, Heinen S, et al.. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood. 2008, 111:5307-15. 10.1182\/blood-2007-08-106153","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre CM","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368:2169-81. 10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh D","year":"2013","unstructured":"Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013, 33:508-30. 10.1016\/j.semnephrol.2013.08.003","journal-title":"Semin Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake JL","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002, 347:589-600. 10.1056\/NEJMra020528","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat C","year":"2011","unstructured":"Loirat C, Fr\u00e9meaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011, 6:60. 10.1186\/1750-1172-6-60","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold DM","year":"2017","unstructured":"Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017, 189:E153-9. 10.1503\/cmaj.160142","journal-title":"CMAJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber J","year":"2011","unstructured":"Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fr\u00e9meaux-Bacchi V, Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol. 2011, 7:23-35. 10.1038\/nrneph.2010.155","journal-title":"Nat Rev Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.01.003","article-title":"Diagnosis and management of complement mediated thrombotic microangiopathies","volume":"28","author":"Cataland SR","year":"2014","unstructured":"Cataland SR, Wu HM. Diagnosis and management of complement mediated thrombotic microangiopathies. Blood Rev. 2014, 28:67-74. 10.1016\/j.blre.2014.01.003","journal-title":"Blood Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab005","article-title":"Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes","volume":"14","author":"Ariceta G","year":"2021","unstructured":"Ariceta G, Fakhouri F, Sartz L, et al.. Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes. Clin Kidney J. 2021, 14:2075-84. 10.1093\/ckj\/sfab005","journal-title":"Clin Kidney J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George JN","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014, 371:654-66. 10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson GL","year":"2022","unstructured":"Thompson GL, Kavanagh D. Diagnosis and treatment of thrombotic microangiopathy. Int J Lab Hematol. 2022, 44:101-13. 10.1111\/ijlh.13954","journal-title":"Int J Lab Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278345-deciphering-complexity-atypical-hemolytic-uremic-syndrome-unraveled-in-the-wake-of-elective-hip-arthroplasty","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:30:45Z","timestamp":1725528645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278345-deciphering-complexity-atypical-hemolytic-uremic-syndrome-unraveled-in-the-wake-of-elective-hip-arthroplasty"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.68690","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}